The obesity treatment market is poised to undergo significant shifts from the balance of products used that are drugs versus devices. While a significant volume of the obesity market is drugs, the drug market potential has yet to be tapped to any significant extent. However, recent FDA moves to reconsider obesity drugs that it previously held up has given the obesity drug market much new life.
Below is illustrated the global market for obesity drugs and devices in both 2011 and 2016.
Source: MedMarket Diligence, LLC; Report #S835, "Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019."